{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:27:33Z","timestamp":1791311253807,"version":"4.3.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["R-148-000-003-001"],"award-info":[{"award-number":["R-148-000-003-001"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["R-148-000-136-112"],"award-info":[{"award-number":["R-148-000-136-112"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["R-148-000-135-112"],"award-info":[{"award-number":["R-148-000-135-112"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ejphar.2012.09.021","type":"journal-article","created":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T14:32:01Z","timestamp":1349361121000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties"],"prefix":"10.1016","volume":"697","author":[{"given":"Sudipta","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra Shu Zhen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chern Yih","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Sun","family":"New","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Keung","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Wei","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Chun Yong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Kiat","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.09.021_bib1","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1021\/tx050353h","article-title":"Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogs and liquid chromatography tandem mass spectrometry","volume":"19","author":"Alvarez-Sanchez","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2012.09.021_bib2","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1073\/pnas.90.11.5123","article-title":"Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens (serum-free medium\/aflatoxin Bi\/benzo[a]pyrene\/n- nitrosodinethylamine)","volume":"90","author":"Andrea","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2012.09.021_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1124\/dmd.104.002683","article-title":"Metabolic activation of pioglitazone identified from rat and human liver microsomes and freshly isolated hepatocytes","volume":"33","author":"Baughman","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2012.09.021_bib4","first-page":"2522","article-title":"Rosiglitazone and cardiovascular risk","volume":"356","author":"Burce","year":"2000","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.ejphar.2012.09.021_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.lfs.2009.04.001","article-title":"Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells","volume":"84","author":"Choi","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2012.09.021_bib6","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1073\/pnas.96.7.3951","article-title":"Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-\u03b3 ligand troglitazone in patients with liposarcoma","volume":"96","author":"Demetri","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2012.09.021_bib7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/tx200110h","article-title":"Toxic metabolite formation from troglitazone (TGZ): newinsights from a DFT Study","volume":"24","author":"Dixit","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2012.09.021_bib8","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptor\u03b3 and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"Elstner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2012.09.021_bib9","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2006.07.2777","article-title":"Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes","volume":"25","author":"Govindarajan","year":"2007","journal-title":"J. Clinic. Oncol."},{"key":"10.1016\/j.ejphar.2012.09.021_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0889-8529(05)70267-X","article-title":"Thiazolidinones","volume":"26","author":"Henry","year":"1997","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"10.1016\/j.ejphar.2012.09.021_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1021\/tx000180q","article-title":"Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission","volume":"14","author":"Kassahun","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2012.09.021_bib12","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/jm049383s","article-title":"Additivity of molecular fields: CoMFA study on dual activators of PPAR\u03b1 and PPAR\u03b3","volume":"48","author":"Khanna","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2012.09.021_bib13","first-page":"1","article-title":"Peroxisome proliferator-activated receptor \u03b3 and cancers. clinic","volume":"9","author":"Koeffler","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2012.09.021_bib14","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0090-9556(24)13660-4","article-title":"The role of conjugation in hepatotoxicity of troglitazone in human and porcine hepatocyte cultures","volume":"28","author":"Kostrubsky","year":"2000","journal-title":"Drug Met. Dispos."},{"key":"10.1016\/j.ejphar.2012.09.021_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/chromsci\/46.3.209","article-title":"Evaluation of BEH C18, BEH HILIC, and HSS T3 (C18) column chemistries for the UPLC-MS-MS analysis of glutathione, glutathione disulfide, and ophthalmic acid in mouse liver and human plasma","volume":"46","author":"New","year":"2008","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.ejphar.2012.09.021_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1172\/JCI10843","article-title":"Treatment of insulin resistance with peroxisome proliferator\u2013activated receptor \u03b3 agonists","volume":"106","author":"Olefsky","year":"2000","journal-title":"J. Clin. Inves."},{"key":"10.1016\/j.ejphar.2012.09.021_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.pharmtox.45.120403.100058","article-title":"The role of metabolic activation in drug-induced hepatotoxicity","volume":"45","author":"Park","year":"2000","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.09.021_bib18","first-page":"165","article-title":"Cell sensitivity assays: the MTT assay","volume":"88","author":"Plumb","year":"2004","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.ejphar.2012.09.021_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","article-title":"Oxidative damage to proteins: spectrophotometric method for carbonyl assay","volume":"233","author":"Reznick","year":"1994","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2012.09.021_bib20","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1054\/bjoc.2001.1821","article-title":"Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma","volume":"84","author":"Rumi","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2012.09.021_bib21","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(11)61663-2","article-title":"Pioglitazone and bladder cancer","volume":"378","author":"Ryder","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2012.09.021_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.toxlet.2009.10.014","article-title":"Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity","volume":"192","author":"Saha","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2012.09.021_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00002018-200124120-00002","article-title":"Hepatotoxicity with thiazolidinediones: is it a class effect?","volume":"24","author":"Scheen","year":"2001","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejphar.2012.09.021_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/jc.2006-1268","article-title":"Peroxisome proliferator-activated receptor gamma and adipose tissue-\u2014understanding obesity-related changes in regulation of lipid and glucose metabolism","volume":"92","author":"Sharma","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2012.09.021_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1021\/tx034033e","article-title":"Mechanisms of troglitazone hepatotoxicity","volume":"16","author":"Smith","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2012.09.021_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.94.1.237","article-title":"Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor \u03b3 and the retinoid X\u2592receptor","volume":"94","author":"Tontonoz","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2012.09.021_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/hep.20994","article-title":"Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo","volume":"43","author":"Yu","year":"2006","journal-title":"Hepatology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912007959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912007959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:16:41Z","timestamp":1757974601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912007959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":27,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0014299912007959"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.09.021","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}